[1] Sun W,Cabrera R. Systemic Treatment of Patients with Advanced.Unresectable HepatocellularCarcinoma:Emergence of Therapies.J Gastrointest Cancer,2018,49:107-115. [2] 陈孝平,朱鹏.以手术治疗为主的肝癌个体化综合治疗.中国实用外科杂志,2016,15:596-598. [3] Gbolahan OB,Schacht MA,Beckley EW, et al.Locoregional and systemic therapy for hepatocellular carcinoma.J Gastrointest Oncol,2017,8:215-228. [4] 王葵,邹奇飞,沈锋,等.肝细胞癌个体化治疗的临床预测模型.临床肝胆病杂志,2018,11:1382-1386. [5] 朱楠,张甜甜,周光亚,等.TACE联合RFA个体化治疗进展期肝癌的疗效.影响研究与医学应用,2019,21:188-189. [6] 沈洁,陈园园,祁亮,等.构建多学科协作的原发性肝癌医疗新模式.中国卫生质量管理,2019,15:93-97. [7] 秦建民.转移性肝癌个体化治疗方案的选择与临床意义.世界华人消化杂志,2018,29:1677-1687. [8] 葛宁灵.肝细胞癌多学科团队(MDT)协作诊疗模式的重要性.胃肠病学和肝病学杂志,2018,12:605-608. [9] 张磊,单忠强,刘树业.原发性肝癌个体化诊疗的研究进展.山东医药,2016,13:96-98. [10] Yoo GS,Yu JI,Park HC.Proton therapy for hepatocellular carcinoma:Current knowledges and future perspectives.World J Gastroenterol,2018,24:3090-3100. [11] Choi SH,Seong J.Strategic application of radiotherapy for hepatocellular carcinoma.Clin Mol Hepatol,2018,24:114-134. [12] Llovet JM,Montal R,Sia D, et al.Molecular therapies and precision medicine for hepatocellular carcinoma.Nat Rev Clin Oncol,2018,19:966-980. [13] Raoul JL,Kudo M,Finn RS, et al. Systemic therapy for intermediate and advanced hepatocellular caicino Sorafenib and beyond.Cancer Treat Rev,2018,68:16-24. [14] Waidmann O. Recent developments with immunotherapy for hepatocellular carcinoma.Expert Opin Biol Ther,2018,18:905-910. [15] Li Z,Li B,Peng D,et al.Expression and clinical significance of PD-1 in hepatocellular carcinoma tissues detected by a novel mouse anti-human PD-1 monoclonal antibody.Int J Oncol,2018,52:2079-2092. [16] Mazzolini GD,Malvicini M.Immunostimulatory monoclonal antibodies for hepatocellular carcinoma therapy Trends and perspectives.Medicina(B Aires),2018,78:29-32. [17] Feng D,Hui X,Shi-Chun L, et al.Initial experience of anti-PD 1 therapy with nivolumab in advanced hepatocellular carcinoma.Oncotarget,2017,8:96649-96655. [18] 汪珍光,周伟平.肝癌不同分期的综合治疗策略及多学科诊疗模式的思考.肝胆外科杂志,2018,8:401-404. [19] 廖毓菁,黄静,胡晓云,等.原发性肝癌患者临床诊疗现状分析及多学科协作诊疗的初步探讨.实用肝脏病杂志,2015,21:512-516. [20] 杨可立,陈敏山,陈锦滨.小肝癌多学科综合治疗方式优化选择.中国实用外科杂志,2016,18:623-627. [21] 荚卫东.精准肝脏外科时代肝癌多学科治疗.实用肝脏病杂志,2015,14:120-123. |